Effects of natriuretic peptides on intracavernous pressure and blood pressure in conscious rats

Journal of Sexual Medicine

Volumn 5, Issue 10, 2008, Pages 2312-2317

  Aizawa, Naoki ^a   Ishizuka, Osamu ^a   Ogawa, Teruyuki ^a   Mizusawa, Hiroya ^b   Igawa, Yasuhiko ^a   Nishizawa, Osamu ^a   Andersson, Karl Erik ^c  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nagano National Hospital   (Japan)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial Natriuretic Peptide; Brain Natriuretic Peptide; C Type Natriuretic Peptide; Natriuretic Peptide; Penile Erection; Rats; Sprague Dawley

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE TYPE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BLOOD PRESSURE MEASUREMENT; BOLUS INJECTION; CONSCIOUSNESS; CONTINUOUS INFUSION; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG EFFECT; DRUG EFFICACY; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SINGLE DRUG DOSE; SPRAGUE DAWLEY RAT; SYSTOLIC BLOOD PRESSURE;

EID: 53549108009     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.00927.x     Document Type: Article

References (19)

1. Saenz de Tejada I, Moroukian P, Tessier J, Kim JJ, Goldstein I, Frohrib D. Trabecular smooth muscle modulates the capacitor function of the penis. Studies on a rabbit model. Am J Physiol 1991;260:H1590-5.
2. Kim N, Azadzoi KM, Goldstein I, Saenz de Tejada I. A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J Clin Invest 1991;88:112-8.
3. Garbers DL. The guanylyl cyclase receptor family. New Biol 1990;2:499-504.
4. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
5. Lin CS, Lin G, Lue TF. Cyclic nucleotide signaling in cavernous smooth muscle. J Sex Med 2005;2:478-91.
6. Singh S, Lowe DG, Thorpe DS, Rodriguez H, Kuang WJ, Dangott LJ, Chinkers M, Goeddel DV, Garbers DL. Membrane guanylate cyclase is a cell-surface receptor with homology to protein kinases. Nature 1988;334:708-12.
7. Chinkers M, Garbers DL, Chang MS, Lowe DG, Chin HM, Goeddel DV, Schulz S. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 1989;338:78-83.
8. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321-8.
9. Kim SZ, Kim SH, Park JK, Koh GY, Cho KW. Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum. J Urol 1998;159:1741-6.
10. Kuthe A, Reinecke M, Uckert S, Becker A, David I, Heitland A, Stief CG, Forssmann WG, Magert HJ. Expression of guanylyl cyclase B in the human corpus cavernosum penis and the possible involvement of its ligand C-type natriuretic polypeptide in the induction of penile erection. J Urol 2003;169:1918-22.
11. Aizawa N, Ishizuka O, Ogawa T, Mizusawa H, Igawa Y, Nishizawa O. Role of 5-HT receptor antagonists in mediating intracavernous pressure response induced by fluvoxamine in conscious rats. J Sex Med 2007;4:1108-16.
12. Andersson KE, Gemalmaz H, Waldeck K, Chapman TN, Tuttle JB, Steers WD. The effect of sildenafil on apomorphine-evoked increases in intracavernous pressure in the awake rat. J Urol 1999;161:1707-12.
13. Ishizuka O, Gu BJ, Nishizawa O, Mizusawa H, Andersson KE. Effect of apomorphine on intracavernous pressure and blood pressure in conscious, spinalized rats. Int J Impot Res 2002;14:128-32.
14. Shono M, Yoshimura M, Nakayama M, Yamamuro M, Abe K, Suzuki S, Mizuno Y, Sugiyama S, Saito Y, Nakao K, Yasue H, Ogawa H. Predominant effect of A-type natriuretic peptide on reduction of oxidative stress during the treatment of patients with heart failure. Circ J 2007;71:1040-6.
15. Hidaka T, Aisaka K, Inomata N, Furuya M, Inoue T, Omata M, Yoshida M, Miyazaki T, Ohno T, Ishihara T. Effect of carperitide (alpha-human atrial natriuretic polypeptide) on the cardiovascular system in experimental animals. Nippon Yakurigaku Zasshi 1993;101:309-25.
16. Ishihara T, Aisaka K, Hattori K, Hamasaki S, Morita M, Noguchi T, Kangawa K, Matsuo H. Vasodilatory and diuretic actions of alpha-human atrial natriuretic polypeptide (alpha-hANP). Life Sci 1985;36:1205-15.
17. Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptides and their receptors. Circulation 1992;86:1081-8.
18. Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Saito Y, Kambayashi Y, Inouye K, Imura H. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 1992;130:229-39.
19. Lappe RW, Smits JF, Todt JA, Debets JJ, Wendt RL. Failure of atriopeptin II to cause arterial vasodilation in the conscious rat. Circ Res 1985;56:606-12.